Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DAGLB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPTBN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDE7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM248 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPKOW - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSEN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NBR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC126 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNAPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRP36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEDD4L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC2A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on